Genome-wide association studies in pharmacogenomics: successes and lessons.

Pharmacogenetics and Genomics
Alison A Motsinger-ReifDan M Roden

Abstract

As genotyping technology has progressed, genome-wide association studies (GWAS) have matured into efficient and effective tools for mapping genes underlying human phenotypes. Recent studies have shown the utility of the GWAS approach for examining pharmacogenomic traits, including drug metabolism, efficacy, and toxicity. Application of GWAS to pharmacogenomic outcomes presents unique challenges and opportunities. In the current review, we discuss the potential promises and potential caveats of this approach specifically as it relates to pharmacogenomic studies. Concerns with study design, power and sample size, and analysis are reviewed. We further examine the features of successful pharmacogenomic GWAS, and describe consortia efforts that are likely to expand the reach of pharmacogenomic GWAS in the future.

References

Sep 13, 1996·Science·N Risch, K Merikangas
Jun 1, 1996·Pharmacogenetics·A K DalyU M Zanger
Oct 16, 2001·Nature Genetics·J P IoannidisD G Contopoulos-Ioannidis
Mar 23, 2002·The Pharmacogenomics Journal·S T WeissL J Palmer
Jun 20, 2003·Nature·Charlotte Westney
Dec 20, 2003·Nature·UNKNOWN International HapMap Consortium
Sep 2, 2004·Nature Reviews. Drug Discovery·Richard Weinshilboum, Liewei Wang
Feb 18, 2005·Nature Reviews. Genetics·Joel N Hirschhorn, Mark J Daly
Jun 3, 2005·The New England Journal of Medicine·Mark J RiederAllan E Rettie
Apr 14, 2006·BMC Bioinformatics·Tricia A Thornton-WellsJonathan L Haines
Nov 23, 2006·Annals of Internal Medicine·Dan M RodenUNKNOWN Pharmacogenetics Research Network
Mar 3, 2007·Clinical Pharmacology and Therapeutics·T S JonesM V Relling
Apr 10, 2008·Nature Reviews. Genetics·Mark I McCarthyJoel N Hirschhorn
Jul 25, 2008·The New England Journal of Medicine·UNKNOWN SEARCH Collaborative GroupR Collins
Aug 30, 2008·Genomics·Ali TorkamaniNicholas J Schork
Sep 23, 2008·Nature Reviews. Drug Discovery·Allen D Roses
Sep 30, 2008·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Eric MickStephen V Faraone
Oct 15, 2008·Human Molecular Genetics·Liewei Wang, Richard M Weinshilboum
Nov 8, 2008·Science·David AltshulerEric S Lander
Nov 21, 2008·Pharmacogenomics·Eric J Peters, Howard L McLeod
Jan 30, 2009·JAMA : the Journal of the American Medical Association·Jun J YangMary V Relling
Feb 12, 2009·Pharmacogenomics·James J CrowleyHoward L McLeod
Feb 21, 2009·The New England Journal of Medicine·UNKNOWN International Warfarin Pharmacogenetics ConsortiumJ A Johnson
Feb 24, 2009·Genetic Epidemiology·Clara C ElbersN Charlotte Onland-Moret
Mar 24, 2009·Journal of General Internal Medicine·Kirsten Neudoerffer KangelarisJeffrey A Tice
May 2, 2009·Blood·Michael A Matthay
May 19, 2009·The American Journal of Psychiatry·Roy H PerlisShaun Purcell

❮ Previous
Next ❯

Citations

May 21, 2011·Bioinformatics·Guy Haskin FernaldRuss B Altman
Jul 31, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·R Michael BaldwinDeanna L Kroetz
May 31, 2012·Circulation·Euan A AshleyUNKNOWN American Heart Association Advocacy Coordinating Committee
Sep 17, 2011·Circulation Research·Dan M RodenRussell A Wilke
Sep 17, 2011·Pharmacogenomics·Andrei S RodinEric Boerwinkle
Sep 4, 2014·Annual Review of Genomics and Human Genetics·J Scott RobertsBeth A Tarini
Jun 6, 2014·Annual Review of Genomics and Human Genetics·Munir Pirmohamed
Nov 13, 2015·Wiley Interdisciplinary Reviews. Systems Biology and Medicine·Mary Regina BolandNicholas P Tatonetti
Apr 11, 2015·Journal of the Peripheral Nervous System : JPNS·Salvatore TerrazzinoGuido Cavaletti
Nov 12, 2015·Pharmacogenomics·Marcelo R Luizon, Nadav Ahituv
Apr 6, 2016·Pharmacogenomics·Maarten LeusinkN Charlotte Onland-Moret
Sep 16, 2015·Clinical Pharmacokinetics·Simran D S MaggoMartin A Kennedy
Apr 11, 2015·Frontiers in Pharmacology·Theodora Katsila, George P Patrinos
Nov 16, 2010·Ageing Research Reviews·Albert C ShawRuth R Montgomery
Mar 23, 2011·Epilepsy & Behavior : E&B·Michael R JohnsonMartin J Brodie
Sep 16, 2016·PloS One·Kleanthi LakiotakiGeorge Potamias
Oct 12, 2016·Clinical Pharmacology and Therapeutics·S M HanM G Lee
Feb 19, 2017·Pharmacology & Therapeutics·Ge Zhang, Daniel W Nebert
Dec 7, 2017·Briefings in Functional Genomics·Bryan J Venters
Nov 3, 2017·Pharmacogenomics·Ricardo PintoRui Medeiros
Dec 24, 2017·Genome Medicine·Charlotta Pauline Irmgard SchärfeDebora Susan Marks
Mar 7, 2018·American Journal of Respiratory and Critical Care Medicine·Angel C Y MakUNKNOWN NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium
Jul 4, 2018·Environmental Health Perspectives·Michele Balik-MeisnerDavid M Reif
Jul 31, 2018·The International Journal of Neuropsychopharmacology·Sheng-Chang WangYu-Li Liu
Jan 8, 2019·Harvard Review of Psychiatry·Eric T WardGabriel Lázaro-Muñoz
May 31, 2018·Cold Spring Harbor Perspectives in Medicine·Ute I SchwarzRichard B Kim
Mar 19, 2019·Pharmacogenomics·Josiah D Allen, Jeffrey R Bishop
Mar 2, 2011·Arthritis and Rheumatism·Robert M Plenge, S Louis Bridges
Dec 10, 2015·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Susannah L CollinsMunir Pirmohamed
Mar 18, 2020·Pharmacogenomics·John S House, Alison A Motsinger-Reif
Feb 12, 2015·Clinical Pharmacology and Therapeutics·T LorberbaumN P Tatonetti
Sep 8, 2020·Pharmacogenomics·Sara Redenšek, Vita Dolžan
Aug 2, 2015·Journal of the American Medical Informatics Association : JAMIA·Guan WangNigam H Shah
Jun 25, 2019·Frontiers in Endocrinology·Fjorda KoromaniLing Oei
Sep 23, 2014·Human Genetics·Sean D Mooney
Dec 8, 2016·Diabetes Care·James S Floyd, Bruce M Psaty

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.